← Eichor
Study identifier: NCT06974851 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

Condition: Bstructive Sleep Apnea (OSA) and Obesity  ·  Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

PhasePhase 3
Planned participants140
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects with Obstructive Sleep Apnea (OSA) and Obesity

This description comes directly from the study's public registry record.

Talk to the study team

Yadi Tang  ·  0518-82342973  ·  yadi.tang.yt37@hengrui.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06974851